Atıf Formatları
The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

e. neslihan Et Al. , "The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers," ESMO 19 th World Congress on Gastroíntestinal Cancer , 2017

neslihan, e. Et Al. 2017. The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers. ESMO 19 th World Congress on Gastroíntestinal Cancer .

neslihan, e., KASAP, E., ÖRENAY BOYACIOĞLU, S., burhan, t., Gerçeker, E., YÜCEYAR, M. H., ... ekti, b. c.(2017). The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers . ESMO 19 th World Congress on Gastroíntestinal Cancer

neslihan, erdem Et Al. "The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers," ESMO 19 th World Congress on Gastroíntestinal Cancer, 2017

neslihan, erdem Et Al. "The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers." ESMO 19 th World Congress on Gastroíntestinal Cancer , 2017

neslihan, e. Et Al. (2017) . "The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers." ESMO 19 th World Congress on Gastroíntestinal Cancer .

@conferencepaper{conferencepaper, author={erdem neslihan Et Al. }, title={The Role of Quantitative TFPI2 Methylation as A Novel Serum Diagnostic and Prognostic Marker in Hepatopancreaticobiliary Cancers}, congress name={ESMO 19 th World Congress on Gastroíntestinal Cancer}, city={}, country={}, year={2017}}